Pharmacotherapeutic Problems and Pharmacist Interventions in a Medical Intensive Care Unit
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: Interest in pharmacist participation in the multidisciplinary intensive care team is increasing. However, studies examining pharmacist interventions in the medical intensive care unit (MICU) are limited in Korea. The aim of this study was to describe the current status of pharmacist interventions and to identify common pharmacologic problems requiring pharmacist intervention in the MICU. Methods: Between September 2013 and August 2014, a retrospective, observational study was conducted in the 22-bed MICU at a university hospital. Data were obtained from two trained pharmacists who participated in MICU rounds three times a week. In addition to patient characteristics, data on the cause, type, related drug, and acceptance rate of interventions were collected. Results: In 340 patients, a total of 1211 pharmacologic interventions were performed. The majority of pharmacologic interventions were suggested by pharmacists at multidisciplinary rounds in the MICU. The most common pharmacologic interventions were adjustment of dosage and administration (n = 328, 26.0%), followed by parenteral/enteral nutritional support (n = 228, 18.1%), the provision of drug information (n = 228, 18.1%), and advice regarding pharmacokinetics (n = 118, 9.3%). Antimicrobial agents (n = 516, 42.6%) were the most frequent type of drug associated with pharmacist interventions. The acceptance rate of interventions was 84.1% with most accepted by physicians within 24 hours (n = 602, 92.8%). Conclusions: Medication and nutritional problems are frequently encountered pharmacotherapeutic problems in the MICU. Pharmacist interventions play an important role in the management of these problems.
Abstract
Background: Interest in pharmacist participation in the multidisciplinary intensive care team is increasing. However, studies examining pharmacist interventions in the medical intensive care unit (MICU) are limited in Korea. The aim of this study was to describe the current status of pharmacist interventions and to identify common pharmacologic problems requiring pharmacist intervention in the MICU. Methods: Between September 2013 and August 2014, a retrospective, observational study was conducted in the 22-bed MICU at a university hospital. Data were obtained from two trained pharmacists who participated in MICU rounds three times a week. In addition to patient characteristics, data on the cause, type, related drug, and acceptance rate of interventions were collected. Results: In 340 patients, a total of 1211 pharmacologic interventions were performed. The majority of pharmacologic interventions were suggested by pharmacists at multidisciplinary rounds in the MICU. The most common pharmacologic interventions were adjustment of dosage and administration (n = 328, 26.0%), followed by parenteral/enteral nutritional support (n = 228, 18.1%), the provision of drug information (n = 228, 18.1%), and advice regarding pharmacokinetics (n = 118, 9.3%). Antimicrobial agents (n = 516, 42.6%) were the most frequent type of drug associated with pharmacist interventions. The acceptance rate of interventions was 84.1% with most accepted by physicians within 24 hours (n = 602, 92.8%). Conclusions: Medication and nutritional problems are frequently encountered pharmacotherapeutic problems in the MICU. Pharmacist interventions play an important role in the management of these problems.
참고문헌 (19)
- Montazeri M, "Impact of a clinical pharmacist in a multidisciplinary intensive care unit", Crit Care Med, 22, pp.1044~1048 (1994)
- Klopotowska JE, "On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm:an intervention study", Crit Care, 14, pp.R174~ (2010)
- Kopp BJ, "Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist", Am J Health Syst Pharm, 64, pp.2483~2487 (2007)
- Anthes AM, "Improving adverse drug event detection in critically ill patients through intensive care unit transfer summary screening", Pharmacoepidemiol Drug Saf, 22, pp.510~516 (2013)
- Kim JM, "Development of clinical pharmacy services for intensive care units in Korea", Springerplus, 3, pp.34~ (2014)
- 강민경, "외과계중환자실 담당약사의 약물유해반응 예방에 대한 처방중재효과", 대한중환자의학회지, 28(1), pp.17~24 (2013), 대한중환자의학회
- 오윤경, "신생아 중환자실 영양요법치료에서 약사의 역할과 영향", 한국임상약학회지, 23(2), pp.167~174 (2013), 한국임상약학회
- Craven DE, "Nosocomial infection and fatality in medical and surgical intensive care unit patients", Arch Intern Med, 148, pp.1161~1168 (1988)
- Jiang SP, "Implementation of pharmacists’ interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital", Ther ClinRisk Manag, 10, pp.861~866 (2014)
- Saokaew S, "Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit", Pharm Pract (Granada), 7, pp.81~87 (2009)
- Moyen E, "Clinical review: medication errors in critical care", Crit Care, 12, pp.208~ (2008)
- Camiré E, "Medication errors in critical care: risk factors, prevention and disclosure", CMAJ, 180, pp.936~943 (2009)
- Cullen DJ, "Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units", Crit Care Med, 25, pp.1289~1297 (1997)
- Kane-Gill S, "Adversedrug-event rates for high-cost and high-use drugs in the intensive care unit", Am J Health Syst Pharm, 63, pp.1876~1881 (2006)
- Zaidi ST, "Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital", Pharm World Sci, 25, pp.299~302 (2003)
- Kaushal R, "Unit-based clinical pharmacists’ prevention of serious medication errors in pediatric inpatients", Am J Health-Syst Pharm, 65, pp.1254~1260 (2008)
- Leape LL, "Pharmacist participation on physician rounds and adverse drug events in the intensive care unit", JAMA, 282, pp.267~270 (1999)
- Agalu A, "Medication prescribing errors in the intensive care unit of Jimma University Specialized Hospital, Southwest Ethiopia", J Multidiscip Healthc, 4, pp.377~382 (2011)
- Bourne RS, "Pharmacist proactive medication recommendations using electronic documentation in a UK general critical care unit", Int J Clin Pharm, 34, pp.351~357 (2012)